Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA.

Coratti G, Civitello M, Rohwer A, Salmin F, Glanzman AM, Montes J, Pasternak A, De Sanctis R, Young SD, Duong T, Mizzoni I, Milev E, Sframeli M, Morando S, Albamonte E, D'Amico A, Brolatti N, Pane M, Scoto M, Messina S, Hirano M, Zolkipli-Cunningham Z, Darras BT, Bertini E, Bruno C, Sansone VA, Day J, Baranello G, Pera MC, Muntoni F, Finkel R, Mercuri E

Open source

DOI: 10.1016/j.nmd.2024.05.003
Published: 2024 Aug
Container: Neuromuscular disorders : NMD
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.nmd.2024.05.003,
  title = {Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA.},
  author = {Coratti G and Civitello M and Rohwer A and Salmin F and Glanzman AM and Montes J and Pasternak A and De Sanctis R and Young SD and Duong T and Mizzoni I and Milev E and Sframeli M and Morando S and Albamonte E and D'Amico A and Brolatti N and Pane M and Scoto M and Messina S and Hirano M and Zolkipli-Cunningham Z and Darras BT and Bertini E and Bruno C and Sansone VA and Day J and Baranello G and Pera MC and Muntoni F and Finkel R and Mercuri E},
  year = {2024},
  journal = {Neuromuscular disorders : NMD},
  doi = {10.1016/j.nmd.2024.05.003},
  url = {https://doi.org/10.1016/j.nmd.2024.05.003}
}

RIS

TY  - JOUR
TI  - Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA.
AU  - Coratti G
AU  - Civitello M
AU  - Rohwer A
AU  - Salmin F
AU  - Glanzman AM
AU  - Montes J
AU  - Pasternak A
AU  - De Sanctis R
AU  - Young SD
AU  - Duong T
AU  - Mizzoni I
AU  - Milev E
AU  - Sframeli M
AU  - Morando S
AU  - Albamonte E
AU  - D'Amico A
AU  - Brolatti N
AU  - Pane M
AU  - Scoto M
AU  - Messina S
AU  - Hirano M
AU  - Zolkipli-Cunningham Z
AU  - Darras BT
AU  - Bertini E
AU  - Bruno C
AU  - Sansone VA
AU  - Day J
AU  - Baranello G
AU  - Pera MC
AU  - Muntoni F
AU  - Finkel R
AU  - Mercuri E
PY  - 2024
JO  - Neuromuscular disorders : NMD
DO  - 10.1016/j.nmd.2024.05.003
UR  - https://doi.org/10.1016/j.nmd.2024.05.003
ER  -

APA

G, C., M, C., A, R., F, S., AM, G., J, M., A, P., R, D. S., SD, Y., T, D., I, M., E, M., M, S., S, M., E, A., A, D., N, B., M, P., M, S., S, M., M, H., Z, Z., BT, D., E, B., C, B., VA, S., J, D., G, B., MC, P., F, M., R, F., & E, M. (2024). Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA.. Neuromuscular disorders : NMD. https://doi.org/10.1016/j.nmd.2024.05.003

Source records

pubmed · retrieved 2026-09-26T05:42:05.299Z